Ahead of key meeting, FDA throws water on Peninsula company’s cancer drug hopes

Geron’s drug for blood cancer patients faces challenges in getting regulatory approval.
Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks